13.07.2015 Views

rologie i - European Congress of Virology

rologie i - European Congress of Virology

rologie i - European Congress of Virology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

5 th <strong>European</strong> <strong>Congress</strong> <strong>of</strong> <strong>Virology</strong>REF 574Possible Involvement <strong>of</strong> Beta herpesviruses HHV 6 and HHV 7 andparvovirus B19 Infection in the Development <strong>of</strong> EncephalopathyModra MUROVSKA 1 , Svetlana CHAPENKO 1 , Santa RASA 1 , SilvijaROGA 2,3 , Zaiga NORA KRUKLE 11 A.Kirchenstein Institute <strong>of</strong> Microbiology and <strong>Virology</strong>, Riga Stradins University,Riga, LATVIA; 2 Chair <strong>of</strong> Pathology, Riga Stradins University,Riga, LATVIA; 3 Riga 1st Hospital, Riga, LATVIAEncephalopathy is a syndrome <strong>of</strong> global brain dysfunction with unclearaetiology. HHV 6 and HHV 7 are neurotropic viruses associated with awide variety <strong>of</strong> neurologic disorders. Involvement <strong>of</strong> B19 in neurologicpathologies is rarely reported.Our study aims to investigate the frequency <strong>of</strong> B19 and HHV 6, HHV7 infection markers in meningeal and brain tissues <strong>of</strong> individuals withunspecified encephalopathy. 34 individuals with and 34 without signs <strong>of</strong>encephalopathy were enrolled in the study. nPCR was used to detect B19,HHV 6 and HHV 7 DNA in autopsy specimens (dura and pia mater, braintissue) and to define HHV 6 variant. Significantly higher frequency <strong>of</strong> viralDNAs detection was found in specimens from individuals with encephalopathycomparing to the control group (32/34 vs. 25/34, p=0.044). Nodifference was detected regarding the presence <strong>of</strong> B19 (17/34 vs. 9/34,p=0.079) and HHV 7 DNA (21/34 vs. 21/34). Frequency <strong>of</strong> single HHV6 infection (8/34 vs. 1/34, p=0.027) and co infections (29/34 vs. 14/34,p=0.0003) was higher in encephalopathy specimens, single HHV 7 infectionin control group’s samples (2/34 vs. 9/34, p=0.044). Frequency <strong>of</strong> B19infection/co infection was higher in pia mater, HHV 6 in brain tissue andpia mater, HHV 7 in brain tissue specimens <strong>of</strong> individuals with encephalopathy.In all HHV 6 positive samples HHV 6B variant was recognized.Meningeal and brain tissues are sites <strong>of</strong> B19, HHV 6, HHV 7 persistency.Simultaneous study <strong>of</strong> these viral infections and their activity stages arerequired to identify the relation with the development <strong>of</strong> encephalopathy.REF 575Identification <strong>of</strong> viral determinants involved in Borna Disease Virusinterference with human neurogenesisChloé SCORDEL 1 , Marielle COCHET 1 , Marion SZELECHOWSKI 2 ,Daniel GONZALEZ DUNIA 2 , Marc ELOIT 1 , Muriel COULPIER 11 UMR1161 de vi<strong>rologie</strong>, ENVA INRA ANSES, Maisons Alfort, FRANCE;2 INSERM, U1043, Toulouse, FRANCEBorna disease virus (BDV) is a neurotropic virus causing neurologicaldisorders and encephalitis in horse and sheep. BDV antigens can be foundin human and the infection could be associated with the development <strong>of</strong>psychiatric disorders. By using human Neural Progenitor Cells (hNPCs)in culture, we previously demonstrated that BDV interferes with humanneurogenesis by inducing the death <strong>of</strong> newly formed neurons. Our researchnow focuses on the identification <strong>of</strong> viral determinants responsible for thisinterference. We used lentiviral vectors containing genes encoding 3 viralproteins, the X protein, the nucleoprotein (N), and the phosphoprotein (P)and demonstrated that these 3 proteins neither interfere with hNPCs proliferationnor with atroglial differentiation. Likewise, the X protein does notimpair neuronal differentiation. On the contrary, N and P strongly impairneuronal differentiation, resulting in a 25 and 50% decrease in the number<strong>of</strong> neurons, respectively. No death was observed in differentiated cellsexpressing N and P, indicating that the two proteins inhibit neuronal differentiationrather than trigger neuronal apoptosis. We next focused on thecharacterization <strong>of</strong> the molecular pathways impaired by P. We found analteration <strong>of</strong> two proteins known to be involved in neurogenesis: the transcriptionalrepressor REST was up regulated and one <strong>of</strong> its targets, SCG10,was down regulated. Our results demonstrate that the phosphoprotein <strong>of</strong>BDV specifically impairs neurogenesis. We are currently pursuing thecharacterization <strong>of</strong> the cellular and molecular mechanisms altered.REF 576Human endogenous retroviruses <strong>of</strong> the HERV W family are upregulatedby the JC polyomavirus in human astrocytesElena ULERI 1 , Elena ULERI 1 , Serra CATERINA 1 , GiuseppeMAMELI 1 , Ilker K SARIYER 2 , Kamel KHALILI 2 , Antonina DOLEI 11 Department <strong>of</strong> Biomedical Sciences, University <strong>of</strong> Sassari, Sassari,ITALY; 2 Department <strong>of</strong> Neuroscience, Center for Neurovirology, TempleUniversity School <strong>of</strong> Medicine, Philadelphia, USAThe ubiquitous JCV polyomavirus causes progressive multifocal leukoencephalopathyin patients severely immunosuppressed or with autoimmunediseases treated with immunosuppressive antibodies. In most <strong>of</strong> thesediseases, upregulation <strong>of</strong> HERV W/MSRV/syncytin 1 endogenous retroviruseswas reported. Since the HERV W/MSRV/syncytin 1 are potentiallyneuropathogenic, we wondered about their interactions with JCV, thatcould contribute to neurodegeneration. Thus, human primary fetal astrocytesand the U87MG cell line were infected by JCV or transfected withexpression plasmids carrying early or late JCV genes, to monitor HERVW/MSRV/syncytin 1 expression, or that <strong>of</strong> constructs carrying the syncytin1 promoter. Infection by JCV upregulated both MSRV like and syncytinenv transcripts. Transient transfection showed that both JCV early and lateproteins stimulate the transcription <strong>of</strong> HERV W/MSRV/syncytin 1 envgenes. As for the HERV W promoter activity in presence <strong>of</strong> JCV proteins,gene reporter experiments with constructs carrying the full length syncytin1 promoter, or promoter deletion mutants, co transfected with JCVearly or late plasmids were carried out. Data indicate that the full lengthpromoter is upregulated by both JCV proteins. Deletion <strong>of</strong> the upstream(cellular) regulatory region indicate that the stimulatory effect lies on the5 ′ LTR (viral) moiety. Due to the identities between the 5 ′ LTR <strong>of</strong> MSRVand syncytin 1, it is likely that up regulation by JCV antigens <strong>of</strong> bothMSRV and syncytin 1 requires mainly the viral moiety <strong>of</strong> their promoters.S280 Vi<strong>rologie</strong>, Vol 17, supplément 2, septembre 2013

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!